Export file:


  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text


  • Citation Only
  • Citation and Abstract

GOF/LOF knowledge inference with tensor decomposition in support of high order link discovery for gene, mutation and disease

1 College of Informatics, Huazhong Agricultural University, 430070, Wuhan, China
2 Hubei Key Lab of Agricultural Bioinformatics, Huazhong Agricultural University, 430070, Wuhan, China
3 College of Science, Huazhong Agricultural University, 430070, Wuhan, China
4 Database Center for Life Science (DBCLS), Research Organization of Information and Systems (ROIS), Tokyo, Japan
5 School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Colorado, U.S

Special Issues: Health Information Processing

For discovery of new usage of drugs, the function type of their target genes plays an important role, and the hypothesis of “Antagonist-GOF” and “Agonist-LOF” has laid a solid foundation for supporting drug repurposing. In this research, an active gene annotation corpus was used as training data to predict the gain-of-function or loss-of-function or unknown character of each human gene after variation events. Unlike the design of(entity, predicate, entity) triples in a traditional three way tensor, a four way and a five way tensor, GMFD-/GMAFD-tensor, were designed to represent higher order links among or among part of these entities: genes(G), mutations(M), functions(F), diseases( D) and annotation labels(A). A tensor decomposition algorithm, CP decomposition, was applied to the higher order tensor and to unveil the correlation among entities. Meanwhile, a state-of-the-art baseline tensor decomposition algorithm, RESCAL, was carried on the three way tensor as a comparing method. The result showed that CP decomposition on higher order tensor performed better than RESCAL on traditional three way tensor in recovering masked data and making predictions. In addition, The four way tensor was proved to be the best format for our issue. At the end, a case study reproducing two disease-gene-drug links(Myelodysplatic Syndromes-IL2RA-Aldesleukin, Lymphoma- IL2RA-Aldesleukin) presented the feasibility of our prediction model for drug repurposing.
  Article Metrics

Keywords drug repurposing; tensor decomposition; relation extraction

Citation: Kaiyin Zhou, YuxingWang, Sheng Zhang, Mina Gachloo, Jin-Dong Kim, Qi Luo, Kevin Bretonnel Cohen, Jingbo Xia. GOF/LOF knowledge inference with tensor decomposition in support of high order link discovery for gene, mutation and disease. Mathematical Biosciences and Engineering, 2019, 16(3): 1376-1391. doi: 10.3934/mbe.2019067


  • 1. M. Simsek, B. Meijer, A. A. van Bodegraven, N. K de Boer, and J. J. M. Chris, Finding hidden treasures in old drugs: the challenges and importance of licensing generics, Drug Discov. Today, 23(2018), 17–21.
  • 2. N C. Baker, S. Ekins, A. J. Williams and A. Tropsha, A bibliometric review of drug repurposing, Drug Discov. Today, (2018).
  • 3. F. L. Hitchcock, The expression of a tensor or a polyadic as a sum of products, J. Math. Phys., 6 (1927), 164–189.
  • 4. N. Maximilian, V. Tresp and H. P. Kriegel, A three-Way model for collective learning on multirelational data, ICML, 11 (2011), 809–816.
  • 5. N. Madhav, M. Gupta and P. Talukdar, Higher-order relation schema induction using tensor factorization with back-o and aggregation, In Proceedings of the 56th Annual Meeting of the Association for Computational Linguistics, 1 (2018), 1575–1584.
  • 6. N. Madhav, U. S. Saini and P. Talukdar, Relation schema induction using tensor factorization with side information, arXiv preprint, arXiv:1605.04227 (2016).
  • 7. L. Timothée, N. Usunier and G. Obozinski, Canonical tensor decomposition for knowledge base completion, arXiv preprint, arXiv:1806.07297 (2018).
  • 8. J. C. Ho, J. Ghosh, S. R. Steinhubl,W. F. Stewart, J. C. Denny, B. A. Malin and J Sun, Limestone: High-throughput candidate phenotype generation via tensor factorization, J. Biomed. Inform., 52 (2014), 199–211.
  • 9. J. Fang and W. Jonathan, Tightly integrated genomic and epigenomic data mining using tensor decomposition, Bioinformatics, (2018), 1–7.
  • 10. Y. H. Taguchi, Identification of candidate drugs using tensor-decomposition-based unsupervised feature extraction in integrated analysis of gene expression between diseases and DrugMatrix datasets, Sci. Rep., 7 (2017), 13733.
  • 11. Y. Wang, X. Yao, K. Zhou, X. Qin, J. D. Kim, K. B Cohen and J. Xia, Guideline design of an active gene annotation corpus for the purpose of drug repurposing, 2018 11th International Congress on Image and Signal Processing, BioMedical Engineering and Informatics(CISP-BMEI 2018), Oct, 2018, Beijing. (Accepted)
  • 12. T. G. Kolda and W. B. Bader, Tensor decompositions and applications. SIAM Rev., 51 (2009), 455–500.
  • 13. R. Stephan, O. Shchur and S. Günnemann, Introduction to tensor decompositions and their applications in machine learning, arXiv preprint, 1711(2017),10781.
  • 14. L. Hao, S. Liang, J. Ye and Z. Xu, TensorD: A tensor decomposition library in TensorFlow, Neurocomputing, 318(2018), 196–200.


This article has been cited by

  • 1. Mina Gachloo, Yuxing Wang, Jingbo Xia, A review of drug knowledge discovery using BioNLP and tensor or matrix decomposition, Genomics & Informatics, 2019, 17, 2, e18, 10.5808/GI.2019.17.2.e18

Reader Comments

your name: *   your email: *  

© 2019 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved